Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO Italy 2020 | Role of NGS in acute leukemias

Torsten Haferlach • 17 Sep 2020
SOHO Italy 2020
Leukemia

Torsten Haferlach, MD, PhD, MLL Munich Leukemia Laboratory, Munich, Germany, discusses the use of next-generation sequencing (NGS) in the diagnosis, follow-up and minimal residual disease measurement of patients with acute leukemias, and how NGS, a rapidly changing field, is an important tool in implementing precision medicine in hematological oncology. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Torsten Haferlach

3:33
The value of WGS and whole transcriptome sequencing in the diagnosis of hematological malignancies
Torsten Haferlach • 9 Dec 2023
1:52
Implementing AI in hematology and the challenges this will overcome
Torsten Haferlach • 9 Dec 2023
2:57
Why do we need AI in the hematology clinic?
Torsten Haferlach • 9 Dec 2023
2:00
MRD detection with NGS for AML: a new era of diagnostics
Torsten Haferlach • 19 Jun 2019

Related Videos

1:25
The role of the bone marrow microenvironment in hematological malignancies
Manja Wobus • 17 Apr 2024
2:06
Managing relapsed ALL: the role of novel cellular therapies & importance of conditioning regimens
Christina Peters • 15 Apr 2024
1:14
Promising novel agents in AML: menin inhibitors
Mark Levis • 16 Apr 2024
3:02
EUPLAGIA-1: Phase I trial of GLPG5201, a CD19 CAR-T product, in R/R CLL and Richter's transformation
Valentin Ortiz-Maldonado • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals